Rana Harb

438 total citations
9 papers, 211 citations indexed

About

Rana Harb is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rana Harb has authored 9 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Rana Harb's work include Prostate Cancer Treatment and Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Rana Harb is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Rana Harb collaborates with scholars based in United States. Rana Harb's co-authors include Emmanuel S. Antonarakis, Mohamad E. Allaf, Charles G. Drake, Karim Boudadi, Zeyad Schwen, Alexa Meyer, Gregory Joice, Michael A. Gorin, Michael E. Zimmerman and Mario A. Eisenberger and has published in prestigious journals such as Journal of Clinical Oncology, Oncotarget and The Prostate.

In The Last Decade

Rana Harb

9 papers receiving 211 citations

Peers

Rana Harb
Rana Harb
Citations per year, relative to Rana Harb Rana Harb (= 1×) peers Antoine Deleuze

Countries citing papers authored by Rana Harb

Since Specialization
Citations

This map shows the geographic impact of Rana Harb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rana Harb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rana Harb more than expected).

Fields of papers citing papers by Rana Harb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rana Harb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rana Harb. The network helps show where Rana Harb may publish in the future.

Co-authorship network of co-authors of Rana Harb

This figure shows the co-authorship network connecting the top 25 collaborators of Rana Harb. A scholar is included among the top collaborators of Rana Harb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rana Harb. Rana Harb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Meyer, Alexa, et al.. (2021). Perirectal hydrogel spacer placement prior to prostate radiation therapy using a probe-mounted needle guide. Clinical and Translational Radiation Oncology. 29. 102–105. 2 indexed citations
2.
3.
Ross, Ashley E., Paula J. Hurley, Phuoc T. Tran, et al.. (2019). A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases. 23(1). 184–193. 36 indexed citations
4.
Gorin, Michael A., Alexa Meyer, Michael E. Zimmerman, et al.. (2019). Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results. World Journal of Urology. 38(8). 1943–1949. 42 indexed citations
5.
Shenderov, Eugene, Angelo M. De Marzo, Karim Boudadi, et al.. (2018). Phase II neoadjuvant and immunologic study of B7-H3 targeting with enoblituzumab in localized intermediate- and high-risk prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). TPS5099–TPS5099. 14 indexed citations
6.
Boudadi, Karim, Daniel L. Suzman, Brandon Luber, et al.. (2017). Phase 2 biomarker-driven study of ipilimumab plus nivolumab (Ipi/Nivo) for ARV7-positive metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(15_suppl). 5035–5035. 24 indexed citations
7.
Ross, Ashley E., Robert M. Hughes, Stephanie Glavaris, et al.. (2017). Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy. Oncotarget. 8(61). 104182–104192. 24 indexed citations
8.
Maughan, Benjamin L., Daniel L. Suzman, Brandon Luber, et al.. (2016). Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 78(6). 1297–1304. 21 indexed citations
9.
Boudadi, Karim, Daniel L. Suzman, Brandon Luber, et al.. (2016). STARVE-PC: Biomarker-driven phase 2 study of ipilimumab plus nivolumab for AR-V7-expressing metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 34(15_suppl). TPS5089–TPS5089. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026